1. Introduction {#sec1}
===============

A recent significant advance in bone biology has been the demonstration that osteoblasts are endocrine cells secreting at least two hormones, FGF23 and osteocalcin [@bib1; @bib2; @bib3]. These two hormones influence a wide range of physiological processes ranging from the phosphate metabolism of FGF23 [@bib1; @bib2], to insulin secretion and glucose homeostasis, testosterone synthesis and male fertility, brain development and cognitive functions for osteocalcin [@bib3; @bib4; @bib5; @bib6; @bib7]. One of the questions raised by this growing body of work is to determine how the expression of these two hormones is controlled. Because of our long-term interest in the biology of this hormone [@bib1; @bib2; @bib3; @bib7], we have addressed this question by studying the regulation *Osteocalcin* expression.

Previous work from other laboratories and ours has identified several transcription factors binding to the promoters of the *Osteocalcin* genes and regulating their expression in the mouse. These include Runx2, which binds to the OSE2 *cis*-acting element present in the promoter of the *Osteocalcin* genes [@bib1; @bib2; @bib8; @bib9], ATF4 that binds to the OSE1 element in the same promoters [@bib3; @bib4; @bib5; @bib6; @bib7; @bib9; @bib10], and FoxO1 [@bib11] and AP-1 [@bib12]. For all these transcription factors, there is genetic evidence that they affect the endocrine functions of osteocalcin [@bib11; @bib13; @bib14; @bib15].

A second level of complexity in the regulation of gene expression is represented by chromatin structure. Class II histone deacetylases (HDACs) are a class of chromatin remodeling enzymes that have a poorly active deacetylase domain, but a long N-terminal domain to which transcription factors can bind. As a result, class II HDACs have often been proposed to link extracellular cues to the genome of a given cell [@bib16; @bib17; @bib18; @bib19; @bib20; @bib21]. Consistent with this view of the functions of class II HDACs, we recently provided evidence that the accumulation of one deacetylase in osteoblasts, HDAC4, is controlled by sympathetic signaling, which favors HDAC4 translocation into the nucleus of osteoblasts, its association with ATF4, and consequently, the regulation of *Rankl* expression by ATF4 [@bib22].

Given the known regulation of *Osteocalcin* expression by ATF4, these data raise the prospect that HDAC4 might also enhance the expression of *Osteocalcin*. Conceivably, HDAC4 may also regulate the expression of other as-yet-unidentified osteoblast-derived hormones, the existence of which was suggested by the discrepancies between the metabolic abnormalities seen in *Osteocalcin−/−* mice and in mice lacking osteoblasts [@bib23]. The present study was initiated to address these questions.

2. Results {#sec2}
==========

2.1. HDAC4 regulates *Osteocalcin* expression {#sec2.1}
---------------------------------------------

As a first approach to determine if HDAC4 could affect some of the long-range functions exerted by the osteoblast, we measured *Osteocalcin* expression in mice lacking *Hdac4* only in osteoblasts (*Hdac4*~*osb*~*−/−*). As shown in [Figure 1](#fig1){ref-type="fig"}A, *Osteocalcin* expression in bone was decreased nearly 4-fold in *Hdac4*~*osb*~*−/−* compared with control mice and more moderately, and not significantly, in *Hdac4*~*osb*~*+/-* mice ([Figure 1](#fig1){ref-type="fig"}A,B). This regulation of *Osteocalcin* expression by class II HDACs appeared to be specific to HDAC4, as mice lacking another class II HDAC, HDAC5, did not experience any decrease in *Osteocalcin* expression ([Figure 1](#fig1){ref-type="fig"}A). To determine if HDAC4 regulates *Osteocalcin* expression in part through its association with ATF4 [@bib22], we generated compound heterozygous mice lacking one copy of *Hdac4* and one copy of *Atf4* in osteoblasts only. As shown previously, this gene deletion strategy removed *Hdac4* and *Atf4* from osteoblasts but not from any other tissues tested ([Figure 1](#fig1){ref-type="fig"}C) [@bib13; @bib22]. *Osteocalcin* expression was significantly decreased in *Atf4*~*osb*~+/−; *Hdac4*~*osb*~*+/*− mice although not to the same extent as in *Hdac4*~*osb*~*−/−* mice ([Figure 1](#fig1){ref-type="fig"}B). This latter observation suggests that HDAC4 may interact with additional transcription factors besides ATF4 to regulate *Osteocalcin* expression. Nevertheless, in agreement with this decrease in *Osteocalcin* expression, the circulating level of all forms of osteocalcin, including its undercarboxylated i.e., active, form were decreased in a statistically significant manner in *Hdac4*~*osb*~*−/−* and *Atf4*~*osb*~+/−;*Hdac4*~*osb*~+/− but not in *Hdac4*~*osb*~+/− or *Atf4*~*osb*~+/− mice when compared with control mice ([Figure 1](#fig1){ref-type="fig"}D). These data indicate that HDAC4 is a regulator of *Osteocalcin* expression in part because it enhances the activity of ATF4 in osteoblasts. This regulation of *Osteocalcin* expression by HDAC4-ATF4 complex appears to be independent of the regulation of HDAC4 activity by the sympathetic nervous system, since *Atf4* expression is normal in *Adrb2*~*osb*~−/− mice (data not shown) and isoproterenol does not regulate *Osteocalcin* expression [@bib24].

2.2. HDAC4 regulates spatial learning through its expression in osteoblasts {#sec2.2}
---------------------------------------------------------------------------

In view of the data presented above, we analyzed whether physiological processes known to be regulated by osteocalcin were affected in *Hdac4*~*osb*~−/− mice. Since the decrease in circulating osteocalcin levels remains moderate in the *Hdac4*~*osb*~−/− mice, we began this analysis by evaluating spatial learning and memory, because of all the functions ascribed to osteocalcin, this is the most clearly affected in *Osteocalcin*+/− mice [@bib5]. For that purpose, control and *Hdac4*~*osb*~−/− mice were subjected to a Morris Water Maze test that analyzes the ability of mice to use spatial cues to locate a submerged platform. Spatial learning was assessed over 3 trials per day for 10 days. As shown in [Figure 2](#fig2){ref-type="fig"}, *Hdac4*~*osb*~−/− mice that demonstrate a more than 50% decrease in circulating osteocalcin levels, experienced an impairment to learn that was comparable in severity to what was observed in *Osteocalcin*+/− mice [@bib5]. We remain aware, however, that HDAC4 through its expression in osteoblasts, could regulate the expression of other hormones affecting spatial learning and memory.

2.3. HDAC4 regulates male fertility through its expression in osteoblasts {#sec2.3}
-------------------------------------------------------------------------

Because this is another physiological function that is severely hampered by the absence of osteocalcin [@bib4] we next studied male fertility in *Hdac4*~*osb*~−/− mice. Testis size and weight were significantly decreased in *Hdac4*~*osb*~−/− male mice at 2 months of age compared to control littermates ([Figure 3](#fig3){ref-type="fig"}A--B). The epididymis and seminal vesicle weight, as well as sperm counts, were also decreased in *Hdac4*~*osb*~−/− male mice, as were the circulating levels of testosterone ([Figure 3](#fig3){ref-type="fig"}C--F).

2.4. HDAC4, through its expression in osteoblasts, regulates energy metabolism in an osteocalcin-dependent and independent manner {#sec2.4}
---------------------------------------------------------------------------------------------------------------------------------

In the last set of experiments, we asked if *Hdac4*, through its expression in osteoblasts, was regulating glucose metabolism. In support of this idea, the circulating levels of insulin were decreased in *Hdac4*~*osb*~−/− *and Atf4*~*osb*~+/−; *Hdac4*~*osb*~+/− but not in *Hdac5*−/− compared with control mice ([Figure 4](#fig4){ref-type="fig"}A,B). In addition, insulin content in the pancreas, as well as β-cell area, were significantly decreased in *Hdac4*~*osb*~−/− compared to *Hdac4f*/*f* control mice ([Figure 4](#fig4){ref-type="fig"}C--D). As a result, insulin secretion, as measured by a glucose stimulated insulin secretion test, was decreased in *Hdac4*~*osb*~−/− mice compared with control littermates ([Figure 4](#fig4){ref-type="fig"}E). All these results are consistent with the notion that HDAC4 regulates glucose metabolism in an osteocalcin-dependent manner. However, unlike what is observed in *Osteocalcin*−/− mice [@bib3], insulin sensitivity as determined by an insulin tolerance test was not affected by the deletion of *Hdac4* from osteoblasts ([Figure 4](#fig4){ref-type="fig"}F). Furthermore, circulating levels of GLP1, another regulator of insulin sensitivity [@bib25; @bib26], were normal in *Hdac4*~*osb*~−/− mice ([Figure 4](#fig4){ref-type="fig"}G). In addition to these disturbances of glucose metabolism, appetite, a function that is not regulated by osteocalcin [@bib3], was significantly decreased in *Hdac4*~*osb*~−/− mice ([Figure 4](#fig4){ref-type="fig"}H). Consequently, body weight was also reduced in *Hdac4*~*osb*~−/− mice ([Figure 4](#fig4){ref-type="fig"}I). This decrease in appetite was not caused by an increase in leptin levels in *Hdac4*~*osb*~−/− mice ([Figure 4](#fig4){ref-type="fig"}J).

Taken together, these results indicate that through its expression in osteoblasts, HDAC4 regulates *Osteocalcin* expression, and many of the endocrine functions this hormone regulates. Through its expression in osteoblasts, *Hdac4* also regulates another metabolic function, appetite, that is not affected by osteocalcin [@bib3]. This latter result indicates that osteoblasts may secrete additional hormone(s) regulating other aspects of energy metabolism such as appetite.

3. Discussion {#sec3}
=============

In this study, we show that the class II HDAC molecule HDAC4 regulates, through its expression in osteoblasts, physiological processes as diverse as spatial learning and memory, male fertility, insulin secretion and appetite. Many, but not all of these functions are regulated by the bone-derived hormone osteocalcin and indeed, *Osteocalcin* expression and circulating levels are lower in *Hdac4*~*osb*~−/− mice than in control mice. These results provide a better molecular understanding of the regulation of the endocrine functions of osteoblasts.

Although they belong to the large family of histone deacetylases, class II HDACs do not usually fulfill a deacetylase function [@bib16; @bib17; @bib18; @bib19; @bib20; @bib21]. Instead, through their long N-terminal domain, they can interact with transcription factors, such as members of the MEF2 family, Runx2 or ATF4 in osteoblasts [@bib22; @bib27]. This is why they have been proposed to act as bridges between extracellular cues and the genome of osteoblasts. For instance, HDAC4 integrates sympathetic signaling in osteoblasts, and consequently regulates osteoclast differentiation [@bib22]. The ability of HDAC4 to interact with and increase the activity of ATF4 was of interest to us, since we have shown previously that ATF4 regulates *Osteocalcin* expression and therefore the endocrine functions of osteoblasts [@bib13].

As one would anticipate given its interaction with ATF4 in osteoblasts, HDAC4 is necessary for proper *Osteocalcin* expression in these cells to maintain normal circulating levels of osteocalcin, and as a result for a variety of functions ascribed to this hormone. Remarkably, the regulation of the endocrine functions of osteoblasts by HDAC4 is specific to this molecule and is not shared by another closely related class II HDAC, HDAC5. Although HDAC4 fulfills some of its functions in an ATF4-dependent manner, our results do not rule out the possibility that HDAC4 could regulate *Osteocalcin* expression and function by interacting with other transcription factors affecting the expression of *Osteocalcin*. Osteocalcin circulating levels are lower in *Hdac4*~*osb*~−/− and *Atf4*~*osb*~+/−;*Hdac4*~*osb*~+/− mice but not all the functions ascribed to osteocalcin are affected in these two mutant mouse strains. For instance, anxiety or insulin sensitivity was normal in these mutant mice. One explanation for these observations may be that to be affected, these functions require even lower levels of circulating osteocalcin than the impaired functions observed in *Hdac4*~*osb*~−/− mice.

In addition, at least one physiological function, the control of appetite, affected in mice lacking *Hdac4* in osteoblasts only is not regulated by osteocalcin in vivo [@bib3]. Therefore, these results suggest that HDAC4 regulates the expression of another osteoblast-secreted hormone regulating appetite. These observations are consistent with Yoshikawa et al., who also observed osteocalcin-independent regulation of energy metabolism in their model of osteoblast ablation [@bib23]. Thus, the results presented in this study imply that the osteoblast is a richer endocrine cell than what has already been described. As such, they are an incentive to embark on a systematic search for other osteoblast-derived hormones that could regulate appetite.

4. Material and methods {#sec4}
=======================

4.1. Mouse generation {#sec4.1}
---------------------

*Hdac4* floxed mice were generated by inserting loxP sites flanking exon 6 that results in an out-of-frame mutation in the *Hdac4* allele (provided by Dr. E. Olson and Dr. R. Bassel-Duby, UT Southwestern, Dallas, Texas) [@bib28]. *Hdac4*~*osb*~−/− mice were generated by intercrossing *Hdac4f*/*f* mice with *Runx2-Cre* transgenic mice [@bib29]. *Hdac5*−/− mice were generated as previously reported [@bib30]. Briefly, the 5′ region of *Hdac5* exon 3 was fused in-frame with the lacZ cDNA and neomycin resistance cassette under the control of the PGK promoter to the 5′ region of exon 3, therefore placing a *β-galactosidase* reporter gene under the control of endogenous *Hdac5* promoter (provided by Dr. E. Olson and Dr. R. Bassel-Duby, UT Southwestern, Dallas, Texas). *Atf4* conditional allele was generated by placing a floxed neo cassette upstream of exon2 and a loxP site downstream of exon3 [@bib13]. *Atf4*~*osb*~*+/−*;*Hdac4*~*osb*~*+/−* mice were generated by crossing *Atf4f/f* or *Atf4f/+* mice with *Hdac4*~*osb*~*+/−* mice. Floxed mice and *Cre* expressing mice littermates (indicated as control in figures) were used as control mice for *Atf4*~*osb*~*+/−*;*Hdac4*~*osb*~*+/−*. Mouse genotypes were determined by PCR. All procedures involving animals were approved by the IACUC and conform to the relevant regulatory standards.

4.2. Metabolic studies {#sec4.2}
----------------------

For insulin tolerance test (ITT) mice were fasted for 4 h and then insulin (0.44 U/kg) was given with intraperitoneal injection (IP). Blood glucose levels were measured at indicated time points using the Accu-Chek active system (Roche). For glucose-stimulated insulin secretion (GSIS) test, mice were fasted for 16 h then injected IP with 3 g/kg of glucose. Blood was collected from the tails of these mice at indicated time points and serum insulin levels were assessed using the Ultra-sensitive Insulin ELISA kit (Crystal Chem). Food intake was measured using metabolic cages as the daily change of food weight.

4.3. Sperm counts {#sec4.3}
-----------------

Caudal epididymides were minced in 1 ml PBS and the number of cells released was counted after 1 h. The total sperm count was assessed in the final suspension by using a hemocytometer [@bib31].

4.4. Hormone measurements {#sec4.4}
-------------------------

Circulating testosterone levels were measured by radioactive immunoassay (Alpco). Random insulin levels in mice were measured in tail blood collected and assayed with the mouse/human insulin ELISA (Mercodia). Total and undercarboxylated osteocalcin levels were quantified using a previously described ELISA [@bib32]. Circulating leptin and GLP1 levels in mice were measured by specific ELISA (Milipore EZML-82K and Raybiotech EIA-GLP1).

4.5. Histology {#sec4.5}
--------------

Pancreatic tissues were fixed in 10% neutral formalin, embedded in paraffin, and sectioned at 5 μm; sections were subjected to immunohistochemistry using an anti-insulin antibody and counterstained with hematoxylin and eosin (H&E). To evaluate cell sizes or numbers, five to ten sections (each 50 μm apart) were analyzed using a 40× objective on a Leica microscope outfitted with a CCD camera (SONY). β-cell area represents the surface positive for insulin immunostaining divided by the total pancreatic surface.

4.6. Gene expression {#sec4.6}
--------------------

RNA isolation, cDNA preparation and quantitative PCR analysis were carried out following standard protocols. Briefly, total RNA was extracted, DNase I-treated and reverse transcribed with random primers using the Superscript III cDNA synthesis kit (Invitrogen, Carlsbad, CA). The cDNA samples were then used as templates for qPCR analysis that was performed using the Taq SYBR Green supermix with ROX (Biorad, Hercules, CA) and specific primers on a Biorad CFX-Connect apparatus. The following primers were used: *Osteocalcin* 5′-AAGCAGGAGGGCAATAAGGT-3′ and 5′-TTTGTAGGCGGTCTTCAAGC-3′ Expression levels of all qPCR reactions were normalized using *Hprt* expression levels as internal control for each sample.

4.7. Morris Water Maze test {#sec4.7}
---------------------------

Animals were transported to the testing room in their home cages, and left undisturbed for at least 30 min prior to the first trial. The maze comprised of a large swimming pool (150 cm diameter) filled with water (23 °C) made opaque with non-toxic white paint. The pool was located in a brightly lit room filled with visual cues, including geometric figures on the walls of the maze demarking the four fixed starting positions of the trials, at (0°, 90°, 180°, and 270°). A 15 cm round platform was hidden 1 cm beneath the surface of the water at a fixed position. Each daily trial block consisted of four swimming trials, with each mouse starting from the same randomly chosen starting position. The starting position varied between days. On days 1--2, mice that failed to find the platform within 2 min were guided to the platform. They had to remain on the platform for 15 s before they were returned to their cages. Mice were not guided to the platform after day 2, and the time it took them to reach the platform over repeated trials (3 trails/day for the next 10 days) was recorded as a measure of spatial learning.

4.8. Statistical analyses {#sec4.8}
-------------------------

Results are given as means ± standard error of the mean (SEM). Statistical analyses were performed using unpaired, two-tailed Student\'s *t*-test. In all figures, error bars represent SEM and \* represents *p* \< 0.05.
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![(A) Analysis of *Osteocalcin* expression in 2-month-old *Hdac4f/f* (*n* = 11), *Hdac4*~*osb*~*−/−(n* = 11) bones. Results are presented as fold changes compared to levels seen in bones of *Hdac4f/f* or WT mice. (B) Analysis of *Osteocalcin* expression in 2-month-old control (*n* = 8), *Atf4*~*osb*~*+/−* (*n* = 2), *Hdac4*~*osb*~*+/−* (*n* = 3), *Atf4*~*osb*~*+/−*;*Hdac4*~*osb*~*+/−* (*n* = 4) bones. Results are presented as fold changes compared to levels seen in bones of control mice. (C) Analysis of *Atf4* and *Hdac4* expression in 2-month-old control (*n* = 8), *Atf4*~*osb*~*+/−* (*n* = 2), *Hdac4*~*osb*~*+/−* (*n* = 3), *Atf4*~*osb*~*+/−*;*Hdac4*~*osb*~*+/−* (*n* = 4) bones. Results are presented as fold changes compared to levels seen in bones of *Hdac4f/f* or control mice. (D) Circulating levels of total and undercarboxylated osteocalcin in *Hdac4f/f* (*n* = 11), *Hdac4*~*osb*~*−/−* (*n* = 11), control (*n* = 8), *Atf4*~*osb*~*+/−* (*n* = 2), *Hdac4*~*osb*~*+/−* (*n* = 3), *Atf4*~*osb*~*+/−*;*Hdac4*~*osb*~*+/−* (*n* = 4) mice. Results are given as means ± SEM. \**p* \< 0.05 by Student\'s *t*-test.](gr1){#fig1}

![(A) Morris water maze test performed over 10 days. The graph shows the time (seconds) needed for 3 month-old *Hdac4f/f* (*n* = 8) and *Hdac4*~*osb*~*−/−* (*n* = 9) mice to localize the platform in the swimming area. Results are given as means ± SEM. \**p* \< 0.05 by Student\'s *t*-test.](gr2){#fig2}

![(A--F) Testis size and weight, epididymes and seminal vesicle weights, sperm count and testosterone levels in 2-months-old *Hdac4*~*osb*~*−/−* (*n* = 5--8) and *Hdac4f/f* (*n* = 5--9) mice. Results are given as means ± SEM. \**p* \< 0.05 by Student\'s *t*-test.](gr3){#fig3}

![(A) Serum insulin levels in 2-month-old *Hdac4f/f* (*n* = 11), *Hdac4*~*osb*~*−/−* (*n* = 11), wild-type (*n* = 8) and *Hdac5−/−* (*n* = 8) mice. (B) Serum insulin levels in control (*n* = 8), *Atf4*~*osb*~*+/−* (*n* = 3), *Hdac4*~*osb*~*+/−* (*n* = 3), *Atf4*~*osb*~*+/−*;*Hdac4*~*osb*~*+/−* (*n* = 4) mice. (C) Insulin content in the pancreata of 2-month-old *Hdac4f/f* (*n* = 7) and *Hdac4*~*osb*~*−/−* (*n* = 8) mice. (D) Histomorphometric analysis of β-cell area (%) in pancreata of 2-month-old *Hdac4f/f* (*n* = 7) and *Hdac4*~*osb*~*−/−* (*n* = 8) mice. (E) Glucose-stimulated insulin secretion (GSIS) test in 2-month-old *Hdac4f/f* (*n* = 7) and *Hdac4*~*osb*~*−/−* (*n* = 6) mice. (F) Insulin tolerance test (ITT) in 2 months-old *Hdac4f/f* (*n* = 12) and *Hdac4*~*osb*~*−/−* (*n* = 7) mice. (G) Serum GLP1 levels in 2-month-old *Hdac4f/f* (*n* = 5), *Hdac4*~*osb*~*−/−* (*n* = 5). (H) Food intake per day. Results are given as means ± SEM. \**p* \< 0.05 by Student\'s *t*-test. (I) Body weight of 2-month-old *Hdac4f/f* (*n* = 5), *Hdac4*~*osb*~*−/−* (*n* = 6) mice. (J) Serum leptin levels in 3-month-old *Hdac4f/f* (*n* = 5), *Hdac4*~*osb*~*−/−* (*n* = 4) mice. Results are given as means ± SEM. \**p* \< 0.05 by Student\'s *t*-test.](gr4){#fig4}
